Related by context. All words. (Click for frequent words.) 76 Oral Presentations 75 Late Breaker 74 Clinical Trial Results 74 Preclinical Data 73 Podium Presentation 73 HCV Protease Inhibitor 72 Treating Chronic 72 Prolongs Survival 72 Poster Presentation 72 Oral Fingolimod 72 Phase 2b Clinical Trial 72 Nicotine Vaccine 72 Pooled Analysis 72 Osteoporosis Treatment 71 Beneficial Effects 71 Oral Presentation 71 Antibiotic Treatment 71 Double Blind Placebo 71 Present Preclinical Data 71 Combination Treatment 71 Randomized Controlled Trials 71 Phase 2b Trial 70 Novel Antibiotic 70 Randomized Trials 70 Phase 2a Trial 70 Therapeutic Vaccines 70 Phase 2a Clinical Trial 70 Phase Ib Clinical Trial 70 Rotavirus Vaccine 70 Inflammatory Arthritis 70 Vaccine Adjuvant 70 Shows Promise Against 70 Adjuvant Chemotherapy 70 Drug Candidate 70 Critically Ill Patients 69 Effectively Treats 69 Nuvelo Announces 69 Fungal Infections 69 Protein Synthesis 69 Systemic Sclerosis 69 IND Application 69 Completes Patient Enrollment 69 Emerging Therapies 69 Completes Enrollment 69 Improve Survival 69 Adjunctive Therapy 69 Appears Safe 69 Randomized Clinical Trial 69 Poster Discussion 69 Clinical Trial Data 69 Collaborators Present 69 Selective Cardiac Myosin 69 Previously Treated 69 Anticancer Activity 69 See CLINICAL PHARMACOLOGY 69 Statin Therapy 69 Study Evaluating 69 Well Tolerated 69 Shows Efficacy 69 Treatment Regimen 69 Therapeutic Targets 69 Improves Survival 69 Phase III Clinical Trial 69 BiTE Antibody 69 Clinical Outcome 69 Diagnostic Tests 69 FDA Okays 69 RNAi Therapeutics 69 Phase III Trials 69 JAK Inhibitor 69 Anticancer Drugs 68 Demonstrates Significant 68 Clinical Efficacy 68 Subtypes 68 Pediatric Patients 68 Spectrum Pharmaceuticals Announces 68 Proves Effective 68 Drug Eluting 68 Relapsing Multiple Sclerosis 68 Novel Approaches 68 Phase IIb Clinical Trial 68 Anti Tumor Activity 68 Multiple Myeloma Patients 68 Meta Analysis 68 Cholesterol Lowering Drug 68 Advanced Ovarian Cancer 68 Submits NDA 68 Investigational Treatment 68 Recombinant Human 68 Liver Toxicity 68 Presents Preclinical Data 68 Mouse Model 68 Initiates Clinical Trial 68 Small Molecule 68 Gene Variants 68 Differential Diagnosis 68 Investigational Compound 68 Chronic Hepatitis B 68 Orally Active 68 Improves Outcomes 68 Preclinical Study 68 Guidelines Issued 68 Phase IIb Trial 68 Carotid Stenting 68 Study Shows Benefits 68 Recombinant Protein 68 Mouse Models 68 Antitumor Activity 68 Immunomedics Announces 68 Urinary Incontinence 68 Seasonal Influenza Vaccine 68 Kidney Transplant Recipients 68 Demonstrated Significant 68 Files IND 68 Immune Responses 68 Long Term Outcomes 68 Chemotherapeutic Agents 68 Genes Linked 68 Advanced Melanoma 68 Antiviral Activity 68 Pharmacyclics Announces 67 Stent Placement 67 Placebo Controlled Trial 67 Shows Promising 67 Topical Treatment 67 Kidney Transplant Patients 67 Serious Infections 67 Test Detects 67 Anticancer Drug 67 Investigational Agent 67 Immune Mediated 67 Clinical Trial Evaluating 67 Dendritic Cells 67 Novel Treatments 67 Renal Cancer 67 Orthop Surg 67 Metastatic Melanoma 67 Meets Primary Endpoint 67 First Patient Dosed 67 Guidelines Recommend 67 Treatment Regimens 67 Biomarker Study 67 Migraine Drug 67 II Clinical Trial 67 Kidney Function 67 Demonstrates Efficacy 67 Single Dose 67 Lung Cancers 67 Hematological Malignancies 67 Immune Cell 67 Rheumatoid Arthritis Patients 67 Colorectal Cancer Patients 67 Improved Survival 67 Patients Treated 67 Preterm Labor 67 Novel Oral 67 Advanced Solid Tumors 67 Drug Combo 67 FDA Approvals 67 Cognitive Impairment 67 Treating Depression 67 Partial Onset Seizures 67 Renal Tumors 67 Neoadjuvant Chemotherapy 67 Slow Progression 67 Lung Cancer Trial 67 Receives Orphan Drug Designation 67 Technological Advances 67 Patients Treated With 67 Novel Method 67 Long Term Efficacy 67 Colorectal Adenomas 67 Inflammatory Diseases 67 Vertebral Fractures 67 Cancer Stem Cells 67 Sinus Infections 67 Breast Ultrasound 67 LENALIDOMIDE 67 Viral Infections 67 Hemodialysis Patients 67 Phase IIa Clinical Trial 67 Abstract Accepted 67 HDAC Inhibitors 67 #nd EORTC NCI 67 Advanced Prostate Cancer 66 Prenatal Diagnosis 66 Lupus Drug 66 Survival Benefit 66 Autoimmune Diseases 66 Upcoming Presentations 66 Hepatitis B Vaccine 66 Total Knee Arthroplasty 66 Drug Shows Promise 66 Prophylactic Treatment 66 Migraine Treatment 66 Demonstrates Potential 66 Proves Successful 66 Antiviral Drugs 66 Protein Biomarkers 66 Preclinical Efficacy 66 Genes Identified 66 Skin Lesions 66 Newly Diagnosed Breast Cancer 66 Severe Sepsis 66 Diabetic Nephropathy 66 Autoimmune Disease 66 Diagnosis Treatment 66 Newly Diagnosed Multiple Myeloma 66 Clostridium difficile Infection 66 Epilepsy Drug 66 Therapeutic Approaches 66 Non Inferiority 66 Minimally Invasive Treatment 66 Lowers Risk 66 Therapeutic Potential 66 Potent Antiviral Activity 66 Postmenopausal Women 66 Patient Enrollment 66 Controlled Trial 66 Elderly Patients 66 HDAC Inhibitor 66 Randomized Clinical Trials 66 Fracture Risk 66 Surgical Procedures 66 Genes Involved 66 J Pediatr 66 Diabetic Kidney Disease 66 Kinase Inhibitor 66 Kidney Transplants 66 Protease Inhibitors 66 HER2 Positive 66 Sangamo BioSciences Announces 66 Estrogen Therapy 66 Hormone Refractory Prostate Cancer 66 Novel Therapeutic 66 Largest Database 66 Crit Rev 66 Overactive Bladder 66 Localized Prostate Cancer 66 Blood Cancers 66 Abstracts Accepted 66 Upcoming Conferences 66 Patients Undergoing 66 Cardiotoxicity 66 Castration Resistant Prostate Cancer 66 Brain Metastases 66 Parenteral Nutrition 66 Randomized Double Blind 66 Targeted Therapies 66 Breast Cancer Recurrence 66 Advanced Renal Cell 66 Contrast Agents 66 Prostate Cancer Vaccine 66 AAEP Convention 66 Cardiovascular Disease Risk 66 Gastrointestinal Disorders 66 Tumor Targeting 66 Help Detect 66 Hsp# Inhibitor 66 Insulin Resistance 66 Pharmacokinetic Study 66 Knee Osteoarthritis 66 RNAi Therapeutic 66 Prospective Randomized 66 Inhaled Corticosteroids 66 Liver Metastases 66 Adjunctive Treatment 66 Stent Implantation 66 Liver Tumors 66 Bone Metastases 66 Diabetic Patients 66 Premature Infants 66 Dry Powder Inhalers 66 Inflammatory Disease 66 NDA Submission 66 Antiviral Therapy 66 Pharmacologic Treatment 66 Successfully Completes Phase 66 Oral Insulin 66 Vaccine Candidate 66 Inherited Diseases 66 Patients Suffering 66 Dosage Forms 66 Subgroup Analysis 66 Transdermal Patch 66 Neural Stem Cells 66 Metastatic Renal Cell Carcinoma 65 Coronary Arteries 65 ASH Annual Meeting 65 FDA Clears 65 Complicated Skin 65 Molecular Diagnostic Test 65 Initiates Phase III 65 Venous Thrombosis 65 Acute Ischemic Stroke 65 Treatment Reduces 65 Novel Inhibitor 65 Prostate Cancer Patients 65 Hepatitis C Treatment 65 Breast Carcinoma 65 Disease Modifying 65 Anti Tumor 65 Inflammatory Response 65 Comorbidities 65 Left Ventricular Hypertrophy 65 Pharmacodynamics 65 Newly Diagnosed 65 Clinical Evaluation 65 Presents Positive 65 Announces Poster Presentations 65 Treat Anemia 65 Phase III Trial 65 Heart Failure Patients 65 FDA Approves Drug 65 Plaque Psoriasis 65 Commonly Used 65 Phase III Clinical Trials 65 Gene Linked 65 Speakers Announced 65 Investigational Drug 65 Hypertensive Patients 65 Therapy Shows Promise 65 Uterine Fibroid Embolization 65 Combination REOLYSIN R 65 Hernia Repair 65 JAK2 Inhibitor 65 Be Cured 65 Novel Therapies 65 Lowers Blood Pressure 65 Initiates Phase II 65 Improve Outcomes 65 Blood Clotting 65 Protein Linked 65 Adjuvant Treatment 65 Novel Small Molecule 65 Oral Cavity 65 Mimetics 65 Curr Opin 65 Symptom Relief 65 Treatment Experienced 65 Prognostic Value 65 Osteoporosis Drugs 65 Ovarian Cancer Patients 65 Pneumococcal Vaccine 65 Orthostatic Hypotension 65 Confirmatory Phase 65 Dose Ranging Study 65 Hepatitis C Genotype 65 Phase 1b Clinical Trial 65 Chronic Hepatitis C 65 Pivotal Phase III 65 Erectile Dysfunction Drug 65 Venous Thromboembolism 65 Systemic Delivery 65 Neuroprotective Effects 65 Renal Function 65 Respiratory Distress 65 Alternative Treatments 65 Adjuvant Therapy 65 Epoetin Alfa 65 Signaling Pathways 65 Soft Tissue Sarcoma 65 Novel Mechanism 65 Surgical Treatment 65 SABCS 65 Tyrosine Kinase Inhibitor 65 Myelodysplastic Syndromes 65 Brentuximab Vedotin SGN 65 Imaging Techniques 65 Confirms Efficacy 65 IND Filing 65 Immunotherapeutic 65 Acute Heart Failure 65 Controlled Study 65 Initiate Clinical Trial 65 Nanoemulsion 65 Eur J 65 Demonstrates Positive 65 Unfractionated Heparin 65 Antiplatelet Therapy 65 Osteoporosis Drug 65 Cutaneous T 65 Lung Cancer Drug 65 Treatment Naïve 65 Randomized Phase 65 Tissue Engineered 65 Adjuvant Breast Cancer 65 Secondary Hyperparathyroidism 65 Hyperlipidemia 65 Replacement Therapy 65 Advanced Colorectal Cancer 65 Gene Variation 65 Myeloma Patients 65 Allergic Reactions 65 Pregnancy Linked 65 Improve Diagnosis 65 ORLive Presents 65 Antigen Specific 65 Epilepsy Drugs 65 Initiates Clinical 65 ASCO GI 65 Treated Patients 65 Vitro Activity 65 Poster Session 65 Metastatic Prostate Cancer 65 Reduce Mortality 65 Fecal Incontinence 65 Progenitor Cells 65 Phase III Pivotal Trial 64 Clinical Trials Update 64 Collaborators Publish 64 Tigecycline 64 Patients Receiving 64 Molecular Diagnostic 64 Teva Provides Update 64 Beta Blocker 64 Systematic Review 64 Dose Finding 64 Enlarged Prostate 64 Resistant Hypertension 64 Glufosfamide 64 Significantly Improved 64 AASLD Meeting 64 Synthetic Peptide 64 Therapeutic Vaccine 64 Reduces Risk 64 Gout Drug 64 Issues Surrounding 64 Innovative Approaches 64 Gentium Announces 64 Chronic Inflammation 64 Stem Cell Treatment 64 AVI BioPharma Announces 64 Transplant Patients 64 Growing Importance 64 Preclinical Models 64 Cancer Immunotherapy 64 Helps Predict 64 Tezampanel 64 Transdermal Delivery 64 Carotid Endarterectomy 64 Proven Effective 64 Hormone Receptor Positive 64 Vaccine Protects Against 64 Proc Am Soc 64 Hepatocellular Carcinoma 64 Molecular Mechanisms 64 Sleep Disturbances 64 Breast Cancers 64 Multicenter Phase 64 Kidney Transplantation 64 Lung Cancer Treatment 64 Reports Preclinical Data 64 Anti Inflammatory 64 Cognitive Function 64 Inflammatory Markers 64 Angiogenic 64 Demonstrates Potent 64 Reduced Risk 64 Chemotherapy Regimen 64 Whole Genome Sequencing 64 Male Infertility 64 Most Widely Used 64 Less Invasive 64 Chronic Myeloid Leukemia 64 Oligonucleotides 64 Liver Failure 64 Annual ICAAC 64 Complete Remission 64 Metabolic Disorder 64 Arthritis Drug 64 Mylan Receives Approval 64 Analytical Methods 64 Cell Transplant 64 Drug Formulation 64 Initiate Phase 64 Dual Antiplatelet Therapy 64 Hematological Cancers 64 Relieve Pain 64 J Am Coll 64 Lung Cancer Survival 64 Cholesterol Drugs 64 Molecular Basis 64 ST Segment Elevation 64 Gets FDA Clearance 64 Genes Associated 64 FDA Accepts 64 Could Prevent 64 Neoplasia 64 Autoimmune Disorders 64 Eye Diseases 64 Catheter Ablation 64 Initiates Enrollment 64 Statistically Significant 64 Gene Mutation 64 Monoclonal Antibodies 64 Cardiovascular Outcomes 64 Gram Negative 64 Therapy Improves 64 Lower Blood Pressure 64 Announce Collaboration Agreement 64 Suppl. 64 Generalized Anxiety Disorder 64 Preclinical Evaluation 64 Aethlon Medical Releases 64 Diabetic Macular Edema 64 Coronary Revascularization 64 Limb Ischemia 64 Severe Asthma 64 Protease Inhibitor 64 Prostate Cancers 64 Inhaled Insulin 64 Postdoctoral Position 64 Data Suggest 64 Non Invasive Treatment 64 Predict Risk 64 ICAAC IDSA 64 Significant Improvement 64 Vaccine Adjuvants 64 Genetic Mutations 64 CT Angiography 64 Increased Mortality 64 Sustained Release 64 Placebo Controlled Study 64 Often Misdiagnosed 64 Randomized Phase III 64 Psoriasis Drug 64 Study Validates 64 Asthma Treatment 64 Regimens 64 Novel Therapeutics 64 Intravenous Formulation 64 Showed Significant 64 Genetic Basis 64 VIVUS Announces 64 Adverse Effects 64 Refractory Angina 64 Cancer Treatments 64 Long Term Survival 64 Dose Ranging 64 NPS Pharmaceuticals Announces 64 Genetic Markers 64 Infected Patients 64 OR Live.com Presents 64 Smoking Linked 64 Plus Ribavirin 64 Significantly Improves 64 Molecular Mechanism 64 Hospitalized Patients 64 Renal Anemia 64 Schizophrenia Treatment 64 Reduces Pain 64 Short Stature 64 Pivotal Study 64 Initiates Dosing 64 Therapeutic Antibodies 64 Cognitive Problems 64 Circulating Tumor Cells 64 Hormonal Therapy 64 Cancer Therapies 64 Pharmacy OneSource Announces 64 Slows Progression 64 Fewer Side Effects 64 Receives Orphan Drug 64 XPEL Announces 64 J Clin 64 Serious Side Effects 64 Maven Semantic 64 Versus Placebo 64 Innate Immunity 64 Endometrial Cancer 64 Telaprevir VX 63 Adenoma 63 Prostate Cancer Treatment 63 Schizophrenia Drug 63 Inhibits 63 AACR symposium 63 Renal Cell Carcinoma 63 Solid Tumors 63 Malignancies 63 Antithrombotic 63 Therapeutic Antibody 63 Submission Deadline 63 BIOLASE Announces 63 Pulmonary Arterial Hypertension 63 Vaginal Gel 63 Tuberculosis Vaccine 63 Cervical Spine 63 Prolongs Life 63 Breaking Clinical Trials 63 Chronic Constipation 63 Immunomodulatory 63 Ocular Diseases 63 Antitumor 63 Randomized Double Blind Placebo 63 Dermatol 63 Hormone Replacement 63 Diabetic Neuropathy 63 Phase 2a Study 63 Combo Therapy 63 Stent Thrombosis 63 Nat Clin Pract 63 Initiate Phase III 63 Randomized Double blind 63 Leukemias 63 Is Well Tolerated 63 Cancer Vaccines 63 Postmenopausal Osteoporosis 63 Pulmonary Vein Isolation 63 Chronic Lymphocytic Leukemia 63 siRNA Delivery 63 Randomized Study 63 Sirolimus Eluting Stent 63 Chronic Renal Failure 63 Immunogenicity 63 Statin Drugs 63 Relapsed Multiple Myeloma 63 Free Full Text 63 Peer Reviewed Journal 63 Develops Novel 63 Taxane 63 PPD Declares 63 AACR #st Annual Meeting 63 Arch Neurol 63 Antibiotic Use 63 Predict Response 63 Threshold Pharmaceuticals Announces 63 Genetic Variations 63 Diabetic Foot Ulcer 63 GRAS Status 63 Ann Rheum Dis 63 Highly Selective 63 Seasonal Allergies 63 Kinase Inhibitors 63 Pivotal Phase 63 Relapsed Refractory 63 Contrast Enhanced 63 Milestone Payment 63 Helps Identify 63 Taro Receives 63 Ozarelix 63 Benign Prostatic Hyperplasia 63 FASEB J. 63 Bazedoxifene 63 ACR ARHP 63 Tumor Growth 63 Aromatase Inhibitors 63 Neuroendocrine Tumors 63 Nucleic Acids 63 Protein Involved 63 Treatment Naive 63 Predict Dementia 63 Atopic Dermatitis 63 Study Proves 63 Inhaled Liposomal Ciprofloxacin 63 Reduces Mortality 63 Patents Issued 63 #-# Full Text 63 Tablet Formulation 63 Announces FDA Clearance 63 Stem Cell Transplants 63 Method Developed 63 Osteoarthritis Patients 63 Breast Cancer Patients 63 Viral Suppression 63 Immune Cells 63 Blood Pressure Drugs 63 Cervical Cancer Vaccine 63 Receives Milestone Payment 63 Phase 2b Study 63 Commercially Available 63 Brain Scans 63 Skeletal Muscle 63 Bare Metal Stents 63 Genetic Testing 63 Prostate Biopsy 63 Malaria Vaccine 63 AACR Meeting 63 Small Molecules 63 Laryngeal Cancer 63 Cause Mortality 63 Help Predict 63 Monoclonal Antibody 63 Pafuramidine 63 Pivotal Clinical Trial 63 Multicenter Study 63 Asthma Medication 63 Cell Transplants 63 Radical Prostatectomy 63 BioElectronics Announces 63 Thrombolytic Therapy 63 Treatment Options 63 Bone Grafting 63 Calcium Supplements 63 Blood Thinning 63 Coronary Artery Calcium 63 Virus Infection 63 Antidepressant Treatment 63 First Patient Enrolled 63 Neurosurg 63 Selective Cardiac Myosin Activator 63 Reflux Disease 63 Treatment Shows Promise 63 AACR San Antonio 63 Pivotal Trial 63 Metastatic Colorectal Cancer 63 Obstet Gynecol 63 Pharmaceuticals Initiates 63 Initiates Phase 63 Dose Escalation 63 Trial Evaluating 63 Urinary Catheter 63 Help Diagnose 63 Significant Reduction 63 Smooth Muscle 63 Metastatic Disease 63 Trodusquemine MSI 63 Tumor Response 63 Histone Deacetylase 63 Ranolazine 63 Menopausal Symptoms 63 Initiates Clinical Trials 63 Gastric Cancer 63 Successfully Treated 63 Novel Compounds 63 Magnetic Nanoparticles 63 Acne Treatments 63 Hypercholesterolemia 63 Educational Webinar 63 Lipid Levels 63 Recurrent Prostate Cancer 63 Growth Hormone Deficiency 63 Glatiramer Acetate 63 Gram Positive 63 Issues Relating 63 Patent Covering 63 Autologous Stem Cell Transplantation 63 Upcoming Investor 63 Female Stress Urinary 63 Poniard Pharmaceuticals Announces 63 Excessive Sweating 63 Intra Arterial 63 Randomized Phase II 63 Treatment Naive Patients 63 Brain Atrophy 63 Stereotaxis Announces 63 Chronic Insomnia 63 Impairs 63 Early Diagnosis 63 Gum Disease 63 #:#-#,# [003] 63 Urine Test 63 Oral Formulation 63 Neuroprotection 63 Oral Insulin Capsule 63 Clinical Outcomes 63 Antipsychotic Drug 63 Brain Tumors 63 R lenalidomide 63 Percutaneous Tibial Nerve Stimulation 63 Diagnostic Criteria 63 Gene Variant 63 Key Milestones 63 UEGW 63 Prostatic 63 Antidepressant Drug 63 ANN INTERN MED 63 #th Interscience Conference 63 Antifungal 63 Gene Mutations 63 Digestive Tract 63 Antigens 63 Previously Untreated 63 Ischemic Stroke 63 Treatment Approaches 63 Oral Calcitonin 63 Announces Presentation 62 Monoclonal 62 Periodontal Disease 62 Imaging Technique 62 Could Revolutionize 62 ECCMID 62 Psychopharmacol 62 Respiratory Virus 62 Gynecol Oncol 62 Genes Predict 62 Receives Approvable Letter 62 Abdominal Fat 62 Gender Differences 62 Pathogen Detection 62 Pivotal Trials 62 Hormone Therapy 62 NASDAQ Listing Requirements 62 Radiation Dose 62 Biomolecules 62 Levels Linked 62 Projected Release Date 62 Orphan Diseases 62 Clin Oncol 62 Biological Therapy 62 EntreMed Presents 62 HIV Integrase 62 Chronic Sinusitis 62 Prognostic Significance 62 Lung Infections 62 Iron Overload 62 Cell Differentiation 62 Antithrombin 62 Metabolic Disease 62 Genetic Variation 62 Chemoradiation 62 Colorectal Screening 62 Prostate Cancer Screening 62 Solid Malignancies 62 Conjugated 62 PRAECIS PHARMACEUTICALS INCORPORATED 62 Cognitive Decline 62 Parathyroid Hormone 62 #st Annual Meeting 62 Effective Than 62 Novel Vaccine 62 Obesity Linked 62 Combination Therapy 62 Arterial Disease 62 Completes Dosing 62 Prospective Multicenter 62 Lung Cancer Patients 62 Interferon Beta 62 Drug Fails 62 ASM Biodefense 62 Presents Preclinical 62 Radiofrequency Ablation 62 Nymox NX 62 Pegylated 62 Intravenous Immunoglobulin 62 Renal Failure 62 Antipsychotic Medications 62 Improving Patient Safety 62 Content Outline 62 Prostate Cancer Cells 62 Nucleoside 62 Receives SFDA Approval 62 Thrombotic 62 Quantum Dots 62 Endovascular Treatment 62 Initiated Phase 62 Sapacitabine 62 Thyroid Hormone 62 Treating Heart Failure 62 PROSTASCINT R 62 Gastrointestinal Disease 62 Breakout Sessions 62 MEK Inhibitor 62 Study Shows Significant 62 Darbepoetin Alfa 62 Multicenter Trial 62 Antidepressants Linked 62 Microalbuminuria 62 Sex Hormones 62 Demonstrates Sustained 62 Files Investigational 62 Being Studied 62 Fondaparinux 62 Drug Resistant 62 RNA Interference 62 Issued Patent 62 Antipsychotic Drugs 62 Blood Pressure Drug 62 Genetic Tests 62 Bone Marrow Cells 62 Hepatocellular 62 Hedgehog Pathway 62 Telik Announces 62 Insulin Glargine 62 Accelr8 Announces 62 Nebulized 62 Clinical Trial Enrollment 62 Flamel Technologies Announces 62 Cardiovascular Risk Factors 62 Male Contraceptive 62 Novel Compound 62 Biologic Drugs 62 Modulates 62 Randomized Controlled 62 Could Detect 62 Induction Therapy 62 Prognostic Factors 62 Biologic Therapy 62 Microplate Readers 62 Anti Inflammatory Drug 62 Breast Tumor 62 Atypical Antipsychotics 62 Artery Disease 62 Contraindications 62 Menstrual Pain 62 Contrast Agent 62 Psychological Effects 62 Low Incidence 62 Psychiatric Disorders 62 Abstract Number 62 Oncolytic 62 Device Helps 62 Retinal Diseases 62 Liver Injury 62 Angioedema 62 Multiple Ascending Dose 62 Cytotoxicity 62 Left Atrial 62 Lupus Nephritis 62 Expanded Indication 62 Unresectable 62 Myoblast 62 Migraine Pain 62 Anti Clotting Drug 62 Significant Improvements 62 Lowering Blood Pressure 62 Receives FDA Clearance 62 Hepatitis C Virus Infection 62 Breast Tissue 62 Endovascular Repair 62 Brain Cells 62 Androgen Receptor 62 Clinically Tested 62 Non Invasive 62 Breast Tumors 62 Demonstrate Significant 62 Therapeutic Efficacy 62 Mitral Valve Repair 62 Bladder Cancer 62 Drug Regimen 62 Optical Sensors 62 Initiates Phase 2b 62 Hazardous Drugs 62 Antiviral Agents 62 Unapproved Drugs 62 Renal Impairment 62 Immune Function 62 Anti CD# Antibody 62 Artificial Pancreas 62 Capsules CII 62 Post Menopausal 62 Smallpox Vaccine 62 Blocked Arteries 62 Protein Interaction 62 Prove Effective 62 Viral Load 62 Anti Angiogenesis 62 Effective Treatments 62 Develop Novel 62 Antiangiogenic 62 Genotypes 62 Platelet Inhibition 62 Diet Linked 62 FDA APPROVES 62 Node Positive 62 Eradicates 62 Bipolar Depression 62 Brain Function 62 Patients Enrolled 62 Respiratory Syncytial Virus 62 Announcement acc 62 Prevent Stroke 62 Muscle Wasting 62 Commences Phase 62 Cervical Dysplasia 62 Placebo Controlled 62 Hospital Acquired Pneumonia 62 Technological Breakthroughs 62 Detect Cancer 62 Noninvasive Prenatal 62 Nat Genet 62 Dialysis Patients 62 Obese Teens 62 C1 Inhibitor 62 Diabetic Neuropathic Pain 62 CyberKnife Radiosurgery 62 Develop Innovative 62 Gene Expression Analysis 62 Being Evaluated 62 Iron Deficiency 62 NanoMarkets Announces 62 Low Dose 62 Ticker Symbol Change 62 Interferon Gamma 62 Begins Dosing 62 Internationally Recognized 62 Cell Adhesion 62 KEMET Announces 62 Study Demonstrates 62 Antibody Therapeutics 62 NMDA Receptor 62 Shown Effective 61 Microfluidic Devices 61 Osteoarthritis Pain 61 J Allergy Clin 61 Genetic Disorder 61 Testosterone Patch 61 Clostridium Difficile Infection 61 Peripheral Blood